We are monitoring the impact of COVID-19 & Recession alarm on APAC Antibodies Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Antibodies Market Research Report – Segmented By Product Type, Indication, End User, Application & By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1115
Pages: 145

APAC Antibodies Market Size (2022 to 2027)

The size of the Antibodies Market in the Asia Pacific was valued at USD 14.23 Billion in 2022. This value is estimated to reach USD 22.78 Billion by the end of 2027, showcasing a growing potential of 9.87% CAGR during the forecast period.

The APAC region has the fastest growth rate of antibodies market in the world. The chronic disease burden of the region is increasing; thus, there is a rise in the research of monoclonal antibodies. The technological advancements and progressive R&D in the field of antibodies in Asia Pacific countries like India, China, Japan, and Australia are majorly expected to propel market growth. Antibodies are used in research to develop new diagnoses and treatments for rare diseases and to study different biomarkers of different conditions. There is significant adoption of therapeutic antibodies in this region, and the regulatory bodies in the area also have approved the treatment at a fast track without affecting safety. There are many antibody products in the clinical trials in the region, and the research has been going in this region to create a vaccine for COVID-19 by using the antibody resistance to coronavirus.

The cost of antibody treatment is high, and the process is complex, restraining the Asia Pacific market growth to some extent. In addition, there are some side effects of the antibody’s treatment like an allergic reaction, flu-like symptoms, vomiting, diarrhea, and low blood pressure, which are predicted to display a negative impact on the market to a limited extent. In addition, less awareness in undeveloped countries is further degrading the market growth. 

This research report on the APAC antibodies market has been segmented and sub-segmented into the following categories:

By Product Type:

  • Monoclonal Antibodies
    • Murine
    • Chimeric
    • Humanized
    • Human
  • Polyclonal Antibodies
    • Type I
    • Type II
    • Type III
    • Type IV
    • Type V
    • Type VI
    • Type VII
    • Type VIII
  • Anti-body drug complexes
    • Immunogen Technology
    • Seattle Genetics Technology
    • Immunomedics Technology

By Indication:

  • Cancer
  • Autoimmune Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • CNS Disorders
  • Others (Inflammatory, Microbial Diseases, & Other)

By End User:

  • Hospitals/Clinics
  • Research institute
  • Diagnostics laboratories

By Application:

  • Medical
  • Experimental
  • Western blot
  • ELISA
  • Radioimmune Assays
  • Immunofluorescence
  • Others (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry)

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regionally, the Indian antibodies market is growing at the highest rate in this region. The National Institute of Immunology (NII) has generated monoclonal antibodies to detect typhoid fever and hepatitis B virus. NII is also developing monoclonal antibodies against rotavirus and virulent strains of E. coli. 

The Chinese antibodies market was leading the Asia Pacific market in 2020. China has many institutes that are researching antibodies. In addition, China is trying to develop a vaccine for COVID-19.

The Japanese government is promoting the production of biosimilar using antibodies. Japan has also developed antibodies for anti-glycosaminoglycan.

KEY MARKET PLAYERS:

Companies that play a promising role in the APAC antibodies market profiled in the report are Abbott Diagnostics, Novartis AG, Pfizer Inc, ThermoFisher Scientific Inc, Eli Lilly and company, A.G. Scientific, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, and AbbVie Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies     

                                                5.1.1.1 Murine

                                                5.1.1.2 Chimeric

                                                5.1.1.3 Humanized

                                                5.1.1.4 Human 

                                5.1.2 Polyclonal Antibodies         

                                                5.1.2.1 Type I

                                                5.1.2.2 Type II

                                                5.1.2.3 Type III

                                                5.1.2.4 Type IV

                                                5.1.2.5 Type V

                                                5.1.2.6 Type VI

                                                5.1.2.7 Type VII

                                                5.1.2.8 Type VIII

                                5.1.3 Antibody-Drug Complexes

                                                5.1.3.1 Immunogen Technology

                                                5.1.3.2 Seattle Genetics Technology

                                                5.1.3.3 Immunomedics Technology

                5.2 By Indication                              

                                5.2.1 Cancer      

                                5.2.2 Autoimmune Diseases       

                                5.2.3 Infectious Diseases             

                                5.2.4 Cardiovascular Diseases    

                                5.2.5 CNS Disorders       

                                5.2.6 Others (Inflammatory, Microbial Diseases, & Other)             

                5.3 End User                     

                                5.3.1 Hospitals/Clinics   

                                5.3.2 Research Institute

                                5.3.3 Diagnostic Laboratories     

                5.4 Application                 

                                5.4.1 Medical    

                                5.4.2 Experimental         

                                                5.4.2.1 Western Blot

                                                5.4.2.2 ELISA

                                                5.4.2.3 Radioimmune Assays 

                                                5.4.2.4 Immunofluorescence 

                                                5.4.2.5 Other (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry)

6. Geographical Analysis                                              

                6.1 Asia-Pacific                 

                                6.1.1 Introduction           

                                6.1.2 China         

                                6.1.3 India          

                                6.1.4 Japan        

                                6.1.5 South Korea           

                                6.1.6 Australia  

7. Pipeline Product Analysis                                        

                7.1 Overview                    

                7.2 Pipeline Development Landscape                     

                7.3 Molecular Targets in the Pipeline                      

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target               

                7.5 Key Trends in Antibodies Development                         

                                7.5.1 Targeted Therapies             

                7.6 Promising Antibodies in Pipeline                       

                7.7 Heat Map of Safety and Efficacy for Pipeline and Marketed Antibodies                            

8.Strategic Analysis                                        

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9.Market Leaders' Analysis                                          

                9.1 Shimadzu Corporation (Japan)                           

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Financial analysis  

                                9.1.4 Recent Developments       

                                9.1.5 SWOT analysis       

                                9.1.6 Analyst View          

                9.2 Novartis AG (Switzerland)                    

                9.3 Pfizer Inc. (U.S.)                       

                9.4 Thermo Fisher Scientific Inc. (U.S.)                   

                9.5 Eli Lilly and Company (U.S.)                 

                9.6 Takara Bio, Inc. (Japan)                         

                9.7 Levena Biopharma (China)                   

                9.9 F. Hoffmann-La Roche Ltd. (Switzerland)                       

                9.10 Bio-Rad Laboratories, Inc. (U.S.)                     

10.Competitive Landscape                                          

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11.Expert Opinions                                         

                11.1 Market Outlook                     

                11.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Asia-Pacific Antibodies Market, By Product type, From 2022 - 2027 (USD Million)
  2. Asia-Pacific Monoclonal Antibodies Market, By Region, From 2022 - 2027 (USD Million)
  3. Asia-Pacific Polyclonal Antibodies Market, By Region, From 2022 - 2027 (USD Million)
  4. Asia-Pacific Antibody-Drug complexes Market, By Region, From 2022 - 2027 (USD Million)
  5. Asia-Pacific Antibodies Market, By Indication, From 2022 - 2027 (USD Million)
  6. Asia-Pacific Cancer Market, By Region, From 2022 - 2027 (USD Million)
  7. Asia-Pacific Auto immune diseases Market, By Region, From 2022 - 2027 (USD Million)
  8. Asia-Pacific infectious diseases Market, By Region, From 2022 - 2027 (USD Million)
  9. Asia-Pacific Cardiovascular diseases Market, By Region, From 2022 - 2027 (USD Million)
  10. Asia-Pacific CNS disorders Market, By Region, From 2022 - 2027 (USD Million)
  11. Asia-Pacific Antibodies Market, By End users, From 2022 - 2027 (USD Million)
  12. Asia-Pacific Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  13. Asia-Pacific Research institute Market, By Region, From 2022 - 2027 (USD Million)
  14. Asia-Pacific Diagnostics laboratories Market, By Region, From 2022 - 2027 (USD Million)
  15. Asia-Pacific Antibodies Market, By Application, From 2022 - 2027 (USD Million)
  16. Asia-Pacific Medical Market, By Region, From 2022 - 2027 (USD Million)
  17. Asia-Pacific Experimental Market, By Region, From 2022 - 2027 (USD Million)
  18. Japan Antibodies Market, By Product type, From 2022 - 2027 (USD Million)
  19. Japan Antibodies Market, By Indication, From 2022 - 2027 (USD Million)
  20. Japan Antibodies Market, By End users, From 2022 - 2027 (USD Million)
  21. Japan Antibodies Market, By Application, From 2022 - 2027 (USD Million)
  22. China Antibodies Market, By Product type, From 2022 - 2027 (USD Million)
  23. China Antibodies Market, By Indication, From 2022 - 2027 (USD Million)
  24. China Antibodies Market, By End users, From 2022 - 2027 (USD Million)
  25. China Antibodies Market, By Application, From 2022 - 2027 (USD Million)
  26. India Antibodies Market, By Product type, From 2022 - 2027 (USD Million)
  27. India Antibodies Market, By Indication, From 2022 - 2027 (USD Million)
  28. India Antibodies Market, By End users, From 2022 - 2027 (USD Million)
  29. India Antibodies Market, By Application, From 2022 - 2027 (USD Million)
  30. Asia-Pacific Antibodies Market, By Monoclonal Antibodies, From 2022 - 2027 (USD Million)
  31. Asia-Pacific Murine Market, By Region, From 2022 - 2027 (USD Million)
  32. Asia-Pacific Chimeric Market, By Region, From 2022 - 2027 (USD Million)
  33. Asia-Pacific Humanized Market, By Region, From 2022 - 2027 (USD Million)
  34. Asia-Pacific Human Market, By Region, From 2022 - 2027 (USD Million)
  35. Japan Antibodies Market, By Monoclonal Antibodies, From 2022 - 2027 (USD Million)
  36. China Antibodies Market, By Monoclonal Antibodies, From 2022 - 2027 (USD Million)
  37. India Antibodies Market, By Monoclonal Antibodies, From 2022 - 2027 (USD Million)
  38. Asia-Pacific Antibodies Market, By Polyclonal Antibodies, From 2022 - 2027 (USD Million)
  39. Asia-Pacific Type I Market, By Region, From 2022 - 2027 (USD Million)
  40. Asia-Pacific Type II Market, By Region, From 2022 - 2027 (USD Million)
  41. Asia-Pacific Type III Market, By Region, From 2022 - 2027 (USD Million)
  42. Asia-Pacific Type IV Market, By Region, From 2022 - 2027 (USD Million)
  43. Asia-Pacific Type V Market, By Region, From 2022 - 2027 (USD Million)
  44. Asia-Pacific Type VI Market, By Region, From 2022 - 2027 (USD Million)
  45. Asia-Pacific Type VII Market, By Region, From 2022 - 2027 (USD Million)
  46. Asia-Pacific Type VIII Market, By Region, From 2022 - 2027 (USD Million)
  47. Japan Antibodies Market, By Polyclonal Antibodies, From 2022 - 2027 (USD Million)
  48. China Antibodies Market, By Polyclonal Antibodies, From 2022 - 2027 (USD Million)
  49. India Antibodies Market, By Polyclonal Antibodies, From 2022 - 2027 (USD Million)
  50. Asia-Pacific Antibodies Market, By Antibody-Drug Complexes, From 2022 - 2027 (USD Million)
  51. Asia-Pacific Immunogen Technology Market, By Region, From 2022 - 2027 (USD Million)
  52. Asia-Pacific Seattle Genetics Technology Market, By Region, From 2022 - 2027 (USD Million)
  53. Asia-Pacific Immunomedics technology Market, By Region, From 2022 - 2027 (USD Million)
  54. Japan Antibodies Market, By Antibody-Drug Complexes, From 2022 - 2027 (USD Million)
  55. China Antibodies Market, By Antibody-Drug Complexes, From 2022 - 2027 (USD Million)
  56. India Antibodies Market, By Antibody-Drug Complexes, From 2022 - 2027 (USD Million)
  57. Asia-Pacific Antibodies Market, By Experimental, From 2022 - 2027 (USD Million)
  58. Asia-Pacific Western Blot Market, By Region, From 2022 - 2027 (USD Million)
  59. Asia-Pacific ELISA Market, By Region, From 2022 - 2027 (USD Million)
  60. Asia-Pacific Radioimmune Assays Market, By Region, From 2022 - 2027 (USD Million)
  61. Asia-Pacific immunofluorescence Market, By Region, From 2022 - 2027 (USD Million)
  62. Japan Antibodies Market, By Experimental, From 2022 - 2027 (USD Million)
  63. China Antibodies Market, By Experimental, From 2022 - 2027 (USD Million)
  64. India Antibodies Market, By Experimental, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample